Skip to content

Taking the potential harms of psychedelic-assisted therapy seriously: How do we prevent or mitigate the risks to vulnerable patients?

Sharon R. Sznitman, Barbara Broers, Reto Auer, Kali Tal

Int J Drug Policy July 26, 2024 DOI: 10.1016/j.drugpo.2024.104521 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Theoretical or philosophical paper Peer reviewed
Topics Psychedelic-assisted therapy
Keywords Psychedelic medicine Psychedelic treatment Patient safety Patient well-being Patient protection Patient safeguards Patient care Risk mitigation Risk management Risk prevention Harm reduction Safety protocols Clinical safeguards Clinical guidelines Best practices Therapeutic protocols Treatment standards Clinical practice
Citations 1
Key points Argues that psychedelic-assisted therapy poses particular risks to vulnerable patients and proposes guidelines to prevent or mitigate those harms.

Abstract

Taking the potential harms of psychedelic-assisted therapy seriously: How do we prevent or mitigate the risks to vulnerable patients?

Explore topics